Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, Follicular × B3(Fv)-PE38KDEL recombinant immunotoxin × Clear all

Sponsor

Conditions

Neoplasms 2 Leukemia 2 Lymphoma, T-Cell, Cutaneous 1 Lymphoma 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Rituximab 117 Cyclophosphamide 67 fludarabine phosphate 43 Whole-Body Irradiation 34 Mycophenolic Acid 31 Peripheral Blood Stem Cell Transplantation 28 Tacrolimus 26 Etoposide 25 Busulfan 23 Filgrastim 22 Lenalidomide 21 Prednisone 20 Cyclosporine 20 Melphalan 19 Bortezomib 19 Antilymphocyte Serum 19 Methotrexate 18 Vincristine 17 obinutuzumab 15 fludarabine 14 Doxorubicin 14 Bendamustine Hydrochloride 14 Dexamethasone 13 pembrolizumab 12 ibrutinib 12 Radiotherapy 12 Granulocyte Colony-Stimulating Factor 12 Cytarabine 12 Cord Blood Stem Cell Transplantation 12 Carmustine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡